张之君先生持股的基本情况 本次减持计划实施前，张之君先生持有公司股份 26,703,050 股，占公司总 股本的 4.9999%；上述股份来源于 2018 年 12 月通过协议转让取得；张之君先生 系公司控股股东贵州神奇控股（集团）公司的一致行动人。 减持计划的实施结果情况 900904 神奇Ｂ股 证券代码：600613 证券简称：神奇制药 公告编号：2026-006 上海神奇制药投资管理股份有限公司 控股股东的一致行动人减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 持公司股份5,340,700股，占公司总股份的1%；通过大宗交易方式减持7,000,000 股，占公司总股份的 1.3107%；减持完成后，张之君先生还持有公司股份 14,362,350 股，占公司总股本的 2.6892%。现将减持情况公告如下： | 股东名称 | 张之君 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | √是 | □否 | | | 直接 ...

上海神奇制药投资管理股份有限公司 关于控股股东的一致行动人权益变动触及 1%刻度的 提示性公告 900904 | 神奇Ｂ股 证券代码：600613 证券简称：神奇制药 公告编号：2026-005 二、 权益变动触及 1%刻度的基本情况 神奇控股及其一致行动人张之君先生保证向本公司提供的信息真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少√ | | --- | --- | --- | --- | | 权益变动前合计比例 | 42.9802% | | | | 权益变动后合计比例 | 41.3249% | | | | 本次变动是否违反已作出的承 | 是□ | 否√ | | | 诺、意向、计划 | | | | | 是否触发强制要约收购义务 | 是□ | 否√ | | 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | √控股股东/实际控制人及其一致行动人 | | --- | --- | | | □其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人 ...

Core Viewpoint - The company has established a financial management system and processes that comply with the requirements for listed companies, aiming to enhance operational efficiency through improved information management [1] Group 1 - The company has implemented a compliant and unified financial information system for its operations [1] - The company is committed to continuously improving its information management level [1] - The goal is to achieve efficient operation of the enterprise [1]

Core Viewpoint - The announcement details the pledge and release of shares by the controlling shareholder of Shanghai Magic Pharmaceutical Investment Management Co., Ltd., indicating no adverse impact on the company's control or operations [2][4]. Group 1: Shareholding and Pledge Details - The controlling shareholder, Guizhou Magic Holdings (Group) Co., Ltd., holds 90,661,620 shares, representing 16.98% of the total share capital. They released 13,430,000 shares from pledge and re-pledged the same amount [2]. - After the transactions, Guizhou Magic Holdings and its subsidiary, Guizhou Magic Investment Management Co., Ltd., collectively hold 178,663,566 shares, which is 33.45% of the total share capital. Their cumulative pledged shares amount to 121,980,000, accounting for 22.84% of the total shares [2][3]. Group 2: Specifics of the Pledge Transactions - The release of 13,430,000 shares represents 2.51% of the total shares and 14.81% of the shares held by Guizhou Magic Holdings. The re-pledge of the same amount has identical percentages [2]. - The pledged shares are not used as collateral for major asset restructuring or performance compensation [2]. Group 3: Impact on Company Operations - The changes in share pledges will not lead to any change in the control of the listed company or adversely affect its production, governance, or performance obligations [4].

Group 1 - The controlling shareholder of the company, Guizhou Magic Holdings Group Co., Ltd., holds 90,661,620 shares, accounting for 16.98% of the total share capital [1] - The company announced the release of a pledge of 13,430,000 shares and simultaneously re-pledged the same amount of shares [1] - The remaining cumulative pledged shares amount to 45,330,000, which represents 8.49% of the total shares and 50.00% of the shares held by the controlling shareholder [1]

上海神奇制药投资管理股份有限公司 关于控股股东股票解除质押及再质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： | | 证券代码：A | | --- | --- | | B | | | 股 | 股 | | 900904 | 600613 | | | 股票简称：A | | B | | | 股 | 股 | | 神奇 | 神奇制药 | | B 股 | 编号：2026-004 | | 股东名称 | 神奇控股 | | | | --- | --- | --- | --- | | 本次解质（解冻）股份 | 13,430,000 | | 股 | | 占其所持股份比例 | 14.81% | | | | 占公司总股本比例 | 2.51% | | | | 解质（解冻）时间 | 2026 年 月 | 1 | 16 日 | 一、解除质押的具体情况 1 | 持股数量 | 90,661,620 股 | | --- | --- | | 持股比例 | 16.98% | | 剩余被质押（被冻结）股份数量 | 31,900,000 ...

Core Viewpoint - The announcement from Magic Pharmaceuticals indicates a recent change in share pledges by its controlling shareholder, Magic Holdings, which does not affect the company's control structure [1] Group 1: Share Pledge Details - On January 16, Magic Holdings completed the release and re-pledge of 13.43 million shares, representing 2.51% of the total shares and 14.81% of its holdings in the company [1] - Magic Holdings currently holds 90.66 million shares, accounting for 16.68% of the total share capital, with 45.33 million shares still pledged, which is 8.49% of the total shares and 50% of its holdings [1] - Together with its controlling company, Magic Holdings owns a total of 179 million shares, which is 33.45% of the total share capital, with cumulative pledges amounting to 122 million shares, representing 22.84% of the total shares and 68.27% of their combined holdings [1]

Core Viewpoint - Guizhou Magic Pharmaceutical (Investment Management) Co., Ltd. announced a "new pledge" operation by its shareholder Guizhou Magic Investment Management Co., Ltd., involving the release and re-pledging of shares [1] Group 1: Share Pledge Operations - On January 14, 2026, Guizhou Magic Investment released a pledge of 23,580,000 shares, accounting for 4.42% of the company's total share capital [1] - The same number of shares, 23,580,000, was re-pledged to Xiamen International Bank for operational funding, with a pledge period from January 14, 2026, to January 13, 2028 [1] - After this operation, Guizhou Magic Investment holds 88,001,946 shares, representing 16.48% of the total share capital, with a total of 76,650,000 shares pledged, which is 87.10% of its holdings and 14.35% of the company's total share capital [1] Group 2: Shareholding Structure - The controlling shareholder, Guizhou Magic Holdings Co., Ltd., and its controlled entity Guizhou Magic Investment together hold 178,663,566 shares, which is 33.45% of the total share capital [1] - Following the pledge changes, the total number of pledged shares by both entities reaches 121,980,000, accounting for 68.27% of their combined holdings and 22.84% of the company's total share capital [1] Group 3: Impact on Company Operations - The announcement indicates that the changes in share pledges will not lead to a change in control of the company and will not adversely affect the company's operations, governance structure, or performance obligations [1]

Core Viewpoint - The company, Shenqi Pharmaceutical, reported that its subsidiary, Guizhou Guangdeli Pharmaceutical Co., Ltd., primarily produces gelatin hollow capsules and plant-based capsules, with some products sold in the EU market [1] Group 1: Company Performance - As of the third quarter of 2025, the subsidiary's revenue reached 53.1371 million yuan, accounting for 3.8% of Shenqi Pharmaceutical's total revenue [1]

| | | 上海神奇制药投资管理股份有限公司 关于股东股票解除质押及再质押的公告 一、解除质押的具体情况 1 | 解质（解冻）时间 | 2026 年 1 | 月 | 14 | 日 | | --- | --- | --- | --- | --- | | 持股数量 | 88,001,946 | | | 股 | | 持股比例 | 16.48% | | | | | 剩余被质押（被冻结）股份数量 | 53,070,000 | | | 股 | | 剩余被质押（被冻结）股份数量占其所持股份比例 | 60.31% | | | | | 剩余被质押（被冻结）股份数量占公司总股本比例 | 9.94% | | | | 二、上市公司股份质押 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 上海神奇制药投资管理股份有限公司（以下简称"公司"或"本公司"） 的股东贵州迈吉斯投资管理有限公司（以下简称"迈吉斯"）持有公司 88,001,946 股，占公司总股本 16.48%；本次解除质押 23,580,000 股，再质押 23,580, ...